Randomized, double-blind, phase III clinical study of a novel nanotechnological topical anesthetic formulation containing lidocaine 25 mg/g and prilocaine 25 mg/g (nanorap) in skin phototypes I-III patients with ablative fractional CO2 laser treatment indication in the forehead

Lasers in Surgery and Medicine
Cíntia GobbatoGilberto De Nucci

Abstract

Nanotechnology may increase the speed of penetration into the skin. This study evaluated the efficacy, safety, and pharmacokinetics of a novel topical anesthetic nanocapsule formulation (2 g) containing 2.5% lidocaine and 2.5% prilocaine (nanorap-test formulation) compared to placebo (control formulation) in skin types I-III patients of both sexes submitted to the ablative fractional CO2 laser treatment. The patients (n = 120) included in this double-blind, single-center, randomized trial, received topical application of 2 g of the test formulation (50 mg lidocaine + 50 mg prilocaine) and placebo on the forehead region. Efficacy was assessed as pain sensation in four quadrants of each side of the forehead using a visual analogue scale immediately (0 min) and at 30, 60, and 90 minutes after laser application compared to placebo. The safety and tolerability of the test product were evaluated based on the occurrence of systemic adverse events as well as the occurrence of immediate and late skin reactions. Pharmacokinetic evaluation was performed in plasma of eight patients using a validated LC-MS/MS method for drugs quantification. Nanorap induced a clinically significant reduction in the pain assessment at all evaluated times (57...Continue Reading

References

Jun 1, 1988·Archives of Dermatology·T B Fitzpatrick
May 5, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M NaguibM Attia
Aug 25, 1999·Journal of the American Academy of Dermatology·D RatnerD J Fader
Sep 1, 1999·The Journal of Investigative Dermatology·C S Leopold, H I Maibach
Jul 25, 2000·Journal of the American Academy of Dermatology·W Huang, A Vidimos
Apr 26, 2002·Journal of Cutaneous Pathology·Huiting DongLorenzo Cerroni
Sep 25, 2002·Journal of the American Academy of Dermatology·Patricia Lee YunR Rox Anderson
Jul 2, 2003·Journal of the American Academy of Dermatology·Elizabeth L TanziTina S Alster
Oct 22, 2003·Archives of Dermatology·Elma D BaronSeth R Stevens
Jun 25, 2004·Lasers in Surgery and Medicine·Dieter MansteinR Rox Anderson
Dec 21, 2004·Contact Dermatitis·J WatonA Barbaud
Sep 6, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Adam J SingerDebbie S Tlockowski
Dec 16, 2005·Pediatric Dermatology·Iria NeriAnnalisa Patrizi
Apr 13, 2006·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Adam J SingerRan Regev
Apr 22, 2008·Journal of the American Academy of Dermatology·Macrene R Alexiades-ArmenakasKenneth A Arndt
Jan 8, 2009·Current Pain and Headache Reports·Jarred YoungerSean Mackey
Feb 19, 2010·Lasers in Surgery and Medicine·Merete HaedersdalR Rox Anderson
May 17, 2011·Journal of the American Academy of Dermatology·Murad AlamKenneth A Arndt
Aug 2, 2013·Seminars in Plastic Surgery·William M Ramsdell
May 17, 2014·Recent Patents on Inflammation & Allergy Drug Discovery·Carmen CantisaniStefano Calvieri
Nov 8, 2014·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Derek ToGillian de Gannes
Jun 3, 2015·Lasers in Surgery and Medicine·Arne A MeestersAlbert Wolkerstorfer
Dec 25, 2015·Journal of Anaesthesiology, Clinical Pharmacology·Mritunjay KumarManish Goyal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.